查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1889502

2025年全球哺乳動物細胞培養市場報告

Mammalian Cell Culture Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，哺乳動物細胞培養市場發展迅速，預計2024年至2025年將以11.2%的複合年成長率從43.7億美元成長至48.6億美元。過去幾年的成長可歸因於單株抗體產量增加、CHO和HEK293細胞株的廣泛應用、疫苗需求的成長、學術和研究實驗室實驗活動的增加以及自體免疫和遺傳性疾病盛行率的上升。

預計未來幾年哺乳動物細胞培養市場將快速成長，到2029年市場規模將達到73.5億美元，複合年成長率（CAGR）為10.9%。預測期內的成長要素包括：對擴充性哺乳動物細胞培養系統的日益重視、細胞療法的廣泛應用、臨床試驗投資的增加、生物製藥生產能力的擴張以及對重組蛋白需求的成長。預測期內的主要趨勢包括：3D細胞培養技術的進步、生物製程最佳化方面的創新、細胞株開發的進展、自動化和高通量篩檢技術的進步以及污染控制和品質保證方面的創新。

未來幾年，對個人化醫療日益成長的需求預計將推動哺乳動物細胞培養市場的成長。個人化醫療是指根據患者的遺傳、環境和生活方式因素來客製化醫療方案，以提供更有效、更精準的治療。對個人化醫療需求的成長源於透過根據個體的遺傳和生物學特徵量身定做治療方法來改善治療效果的能力。哺乳動物細胞培養在個人化醫療中發揮關鍵作用，它提供了一個可控的環境，用於研究患者的獨特細胞，從而開發個人化治療方法並測試藥物反應。例如，根據美國非營利組織個人化醫療聯盟（Personalized Medicine Coalition）2024年2月發布的消息，美國食品藥物管理局（FDA）在2023年核准了16種用於治療罕見疾病患者的新型個人化療法，較2022年的6種顯著增加。因此，對個人化醫療日益成長的需求正在推動哺乳動物細胞培養市場的成長。

哺乳動物細胞培養市場的主要企業正致力於培養基的創新，例如雙組分培養基，以提高蛋白質產量、增強細胞活力並簡化可擴展的生物製程流程，從而應用於治療領域。雙組分培養基系統是一種細胞培養方法，它使用兩種不同的培養基成分——一種支持細胞的正常生長，另一種促進蛋白質表現——以提高整體生產效率。例如，總部位於瑞士的合約研發生產機構 (CDMO) Lonza 集團於 2023 年 7 月推出了 TheraPRO CHO 培養基系統。這款化學成分明確、不含動物源成分的培養基系統專為 GS-CHO 哺乳動物細胞株設計。該系統旨在透過提高細胞活力和蛋白質產量來提高治療性蛋白質和單株抗體的生產效率。其可擴展的設計支持從細胞株開發到大規模生產的各個生物製程生產階段。 Lonza 希望透過該產品幫助生物製藥生產商簡化工作流程、提高產品品質並縮短產品上市時間。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球哺乳動物細胞培養市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 終端用戶產業分析
  • 全球哺乳動物細胞培養市場：成長率分析
  • 全球哺乳動物細胞培養市場表現：規模與成長，2019-2024年
  • 全球哺乳動物細胞培養市場預測：規模與成長，2024-2029年，2034年預測
  • 全球哺乳動物細胞培養市場：潛在市場規模（TAM）

第6章 市場細分

  • 全球哺乳動物細胞培養市場：依產品、效能及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 培養基
  • 血清
  • 試劑
  • 裝置
  • 全球哺乳動物細胞培養市場（依細胞株系、表現及預測分類，2019-2024年、2024-2029年預測、2034年預測）
  • 中國倉鼠卵巢細胞（CHO）
  • 韋斯特研究所-38 (WI-38)
  • 大鼠神經癌細胞株（C6）
  • 人類胚胎腎293細胞（HEK293）
  • 亨麗埃塔·拉克斯（HeLa）
  • 全球哺乳動物細胞培養市場：依應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 生物製藥生產
  • 疫苗生產
  • 毒性測試
  • 藥物篩檢與開發
  • 組織工程與再生醫學
  • 全球哺乳動物細胞培養市場：依最終用途分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 製藥和生物技術公司
  • 醫院和診斷檢查室
  • 研究和學術機構
  • 合約研究組織（CRO）
  • 全球哺乳動物細胞培養市場：依培養基、類型、表現及預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 無血清培養基
  • 化學成分明確的培養基
  • 傳統媒體
  • 無蛋白培養基
  • 特殊培養基
  • 客製化媒體準備
  • 全球哺乳動物細胞培養市場：依血清、類型、表現及預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 牛（FBS）
  • 新生牛血清
  • 成人牛血清
  • 供體馬血清
  • 全球哺乳動物細胞培養市場：依試劑、類型、表現及預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 生長因子和細胞激素
  • 細胞分散試劑
  • 補充劑和添加劑
  • 冷凍保護劑
  • 緩衝液和鹽溶液
  • 抗生素和抗真菌藥
  • 全球哺乳動物細胞培養市場：按設備、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 生物反應器和發酵罐
  • 培養容器
  • 過濾系統
  • 離心機
  • 細胞計數器和分析儀
  • 培養箱
  • 生物安全櫃
  • 顯微鏡
  • 冷藏/低溫儲存設備

第7章 區域和國家分析

  • 全球哺乳動物細胞培養市場：區域表現與預測，2019-2024年、2024-2029年預測、2034年預測
  • 全球哺乳動物細胞培養市場：依國家、績效及預測分類，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 哺乳動物細胞培養市場：競爭格局
  • 哺乳動物細胞培養市場：公司概況
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Becton Dickinson and Company
  • Lonza Group AG
  • Avantor Inc.
  • Agilent Technologies Inc.
  • Charles river laboratories
  • Sartorius AG
  • Samsung biologics
  • Wuxi biologics
  • Bio-Techne Corporation
  • Miltenyi Biotec
  • STEMCELL Technologies
  • Takara Bio Inc.
  • Goodwin biotechnology
  • HiMedia Laboratories Private Limited
  • Promocell GmbH

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年哺乳動物細胞培養市場：提供新機會的國家
  • 2029年哺乳動物細胞培養市場：新興細分市場機會
  • 2029年哺乳動物細胞培養市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r40050

Mammalian cell culture is the process of growing animal cells under controlled laboratory conditions outside their natural environment. It involves maintaining cells in a nutrient-rich medium that supplies essential growth factors, gases, and conditions such as temperature and pH. This technique is widely used in research, biotechnology, and medicine for studying cell biology, producing vaccines, and testing drugs. It enables scientists to simulate in vivo conditions and observe cellular behavior in a controlled setting.

The main products used in mammalian cell culture include media, sera, reagents, and equipment. Media refers to nutrient-rich formulations designed to support the growth, proliferation, and maintenance of mammalian cells under controlled laboratory conditions. Key cell lines include Chinese hamster ovary (CHO), Wistar Institute-38 (WI-38), rat glial tumor cell line (C6), human embryonic kidney 293 (HEK293), and Henrietta Lacks (HeLa). Major applications span biopharmaceutical production, vaccine production, toxicity testing, drug screening and development, and tissue engineering and regenerative medicine, with primary end users including pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, research and academic institutes, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The mammalian cell culture market research report is one of a series of new reports from The Business Research Company that provides mammalian cell culture market statistics, including the mammalian cell culture industry global market size, regional shares, competitors with the mammalian cell culture market share, detailed mammalian cell culture market segments, market trends, and opportunities, and any further data you may need to thrive in the mammalian cell culture industry. This mammalian cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The mammalian cell culture market size has grown rapidly in recent years. It will grow from $4.37 billion in 2024 to $4.86 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. Growth during the historic period can be attributed to the increasing production of monoclonal antibodies, the rising use of CHO and HEK293 cell lines, growing demand for vaccines, expansion of academic and research laboratory activities, and the increasing prevalence of autoimmune and genetic disorders.

The mammalian cell culture market size is expected to see rapid growth in the next few years. It will grow to $7.35 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. Growth in the forecast period can be attributed to a stronger focus on scalable mammalian cell culture systems, greater adoption of cell-based therapies, rising investment in clinical trials, expansion of biopharmaceutical manufacturing capabilities, and increasing demand for recombinant proteins. Major trends expected in the forecast period include technological advancements in 3D cell culture, innovations in bioprocess optimization, progress in cell line development, advancements in automation and high-throughput screening, and innovations in contamination control and quality assurance.

The increasing demand for personalized medicine is expected to drive the growth of the mammalian cell culture market in the coming years. Personalized medicine tailors medical treatment based on a patient's genetic, environmental, and lifestyle factors to provide more effective and precise care. The rise in demand for personalized medicine is driven by its ability to improve treatment outcomes by customizing therapies to an individual's genetic and biological profile. Mammalian cell culture plays a key role in personalized medicine by providing a controlled environment to study patient-specific cells, enabling the development of tailored therapies and testing drug responses for more accurate and effective treatments. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 new personalized treatments for patients with rare diseases in 2023, a significant increase from the six approved in 2022. As a result, the increasing demand for personalized medicine is fueling the growth of the mammalian cell culture market.

Leading companies in the mammalian cell culture market are focusing on innovation in cell culture media, such as two-part production systems, to improve protein yield, enhance cell viability, and streamline scalable bioprocess workflows for therapeutic applications. A two-part production system is a cell culture method that uses two distinct media components: one to support general cell growth and the other to boost protein expression, improving overall productivity. For example, in July 2023, Lonza Group Ltd., a Switzerland-based contract development and manufacturing organization (CDMO), launched the TheraPRO CHO Media System. This chemically defined, animal-component-free media system is designed specifically for GS-CHO mammalian cell lines. It aims to enhance the production of therapeutic proteins and monoclonal antibodies by improving cell viability and protein yields. Its scalable design supports all stages of bioprocess manufacturing, from cell line development to large-scale production. With this launch, Lonza seeks to streamline workflows, improve product quality, and accelerate time-to-market for biopharmaceutical manufacturers.

In December 2024, Merck KGaA, a Germany-based science and technology company, acquired HUB Organoids Holding B.V. for an undisclosed amount. This acquisition aims to advance Merck's next-generation biology portfolio by integrating HUB's organoid technology to accelerate drug discovery, expand 3D cell-culture capabilities, and provide human-relevant models for disease modeling and toxicity testing. HUB Organoids Holding B.V., based in the Netherlands, specializes in mammalian cell culture-based organoid models that replicate human organ structure and function for research and therapeutic applications.

Major companies operating in the mammalian cell culture market are Novartis AG, Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, GE Healthcare, Becton Dickinson and Company, Lonza Group AG, Avantor Inc., Agilent Technologies Inc., Charles river laboratories, Sartorius AG, Samsung biologics, Wuxi biologics, Bio-Techne Corporation, Miltenyi Biotec, STEMCELL Technologies, Takara Bio Inc., Goodwin biotechnology, HiMedia Laboratories Private Limited, Promocell GmbH, Eppendorf AG, Cell Culture Company LLC, Cell X Technologies.

North America was the largest region in the mammalian cell culture market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in mammalian cell culture report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mammalian cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mammalian cell culture market consists of sales of media, sera, reagents, equipment, bioreactors, culture plates, flasks, incubators, centrifuges, and microscopes. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mammalian Cell Culture Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mammalian cell culture market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mammalian cell culture ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The mammalian cell culture market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Media; Sera; Reagents; Equipment
  • 2) By Cell Line: Chinese Hamster Ovary (CHO); Wistar Institute-38 (WI-38); Rat Glial Tumor Cell Line (C6); Human Embryonic Kidney 293 (HEK293); Henrietta Lacks (HeLa)
  • 3) By Application: Biopharmaceutical Production; Vaccine Production; Toxicity Testing; Drug Screening and Development; Tissue Engineering And Regenerative Medicine
  • 4) By End-Use: Pharmaceutical And Biotechnology Companies; Hospitals And Diagnostic Laboratories; Research And Academic Institutes; Contract Research Organizations (CROS)
  • Subsegments:
  • 1) By Media: Serum-free Media; Chemically Defined Media; Classical Media; Protein-free Media; Specialty Media; Custom Media Formulations
  • 2) By Sera: Fetal Bovine Serum (FBS); Newborn Calf Serum; Adult Bovine Serum; Donor Horse Serum
  • 3) By Reagents: Growth Factors And Cytokines; Cell Dissociation Reagents; Supplements And Additives; Cryoprotective Agents; Buffers And Salt Solutions; Antibiotics And Antimycotics
  • 4) By Equipment: Bioreactors And Fermenters; Culture Vessels; Filtration Systems; Centrifuges; Cell Counters And Analyzers; Incubators; Biosafety Cabinets; Microscopes; Refrigeration And Cryostorage Equipment
  • Companies Mentioned: Novartis AG; Thermo Fisher Scientific Inc.; Merck KGaA; Danaher Corporation; GE Healthcare; Becton Dickinson and Company; Lonza Group AG; Avantor Inc.; Agilent Technologies Inc.; Charles river laboratories; Sartorius AG; Samsung biologics; Wuxi biologics; Bio-Techne Corporation; Miltenyi Biotec; STEMCELL Technologies; Takara Bio Inc.; Goodwin biotechnology; HiMedia Laboratories Private Limited; Promocell GmbH; Eppendorf AG; Cell Culture Company LLC; Cell X Technologies.
  • Countries:

Table of Contents

1. Executive Summary

2. Mammalian Cell Culture Market Characteristics

3. Mammalian Cell Culture Market Trends And Strategies

4. Mammalian Cell Culture Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Mammalian Cell Culture Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Mammalian Cell Culture PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Mammalian Cell Culture Market Growth Rate Analysis
  • 5.4. Global Mammalian Cell Culture Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Mammalian Cell Culture Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Mammalian Cell Culture Total Addressable Market (TAM)

6. Mammalian Cell Culture Market Segmentation

  • 6.1. Global Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Media
  • Sera
  • Reagents
  • Equipment
  • 6.2. Global Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Chinese Hamster Ovary (CHO)
  • Wistar Institute-38 (WI-38)
  • Rat Glial Tumor Cell Line (C6)
  • Human Embryonic Kidney 293 (HEK293)
  • Henrietta Lacks (HeLa)
  • 6.3. Global Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biopharmaceutical Production
  • Vaccine Production
  • Toxicity Testing
  • Drug Screening and Development
  • Tissue Engineering And Regenerative Medicine
  • 6.4. Global Mammalian Cell Culture Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Hospitals And Diagnostic Laboratories
  • Research And Academic Institutes
  • Contract Research Organizations (CROS)
  • 6.5. Global Mammalian Cell Culture Market, Sub-Segmentation Of Media, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Serum-free Media
  • Chemically Defined Media
  • Classical Media
  • Protein-free Media
  • Specialty Media
  • Custom Media Formulations
  • 6.6. Global Mammalian Cell Culture Market, Sub-Segmentation Of Sera, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fetal Bovine Serum (FBS)
  • Newborn Calf Serum
  • Adult Bovine Serum
  • Donor Horse Serum
  • 6.7. Global Mammalian Cell Culture Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Growth Factors And Cytokines
  • Cell Dissociation Reagents
  • Supplements And Additives
  • Cryoprotective Agents
  • Buffers And Salt Solutions
  • Antibiotics And Antimycotics
  • 6.8. Global Mammalian Cell Culture Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bioreactors And Fermenters
  • Culture Vessels
  • Filtration Systems
  • Centrifuges
  • Cell Counters And Analyzers
  • Incubators
  • Biosafety Cabinets
  • Microscopes
  • Refrigeration And Cryostorage Equipment

7. Mammalian Cell Culture Market Regional And Country Analysis

  • 7.1. Global Mammalian Cell Culture Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Mammalian Cell Culture Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mammalian Cell Culture Market

  • 8.1. Asia-Pacific Mammalian Cell Culture Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mammalian Cell Culture Market

  • 9.1. China Mammalian Cell Culture Market Overview
  • 9.2. China Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mammalian Cell Culture Market

  • 10.1. India Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mammalian Cell Culture Market

  • 11.1. Japan Mammalian Cell Culture Market Overview
  • 11.2. Japan Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mammalian Cell Culture Market

  • 12.1. Australia Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mammalian Cell Culture Market

  • 13.1. Indonesia Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mammalian Cell Culture Market

  • 14.1. South Korea Mammalian Cell Culture Market Overview
  • 14.2. South Korea Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mammalian Cell Culture Market

  • 15.1. Western Europe Mammalian Cell Culture Market Overview
  • 15.2. Western Europe Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mammalian Cell Culture Market

  • 16.1. UK Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mammalian Cell Culture Market

  • 17.1. Germany Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mammalian Cell Culture Market

  • 18.1. France Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mammalian Cell Culture Market

  • 19.1. Italy Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mammalian Cell Culture Market

  • 20.1. Spain Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mammalian Cell Culture Market

  • 21.1. Eastern Europe Mammalian Cell Culture Market Overview
  • 21.2. Eastern Europe Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mammalian Cell Culture Market

  • 22.1. Russia Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mammalian Cell Culture Market

  • 23.1. North America Mammalian Cell Culture Market Overview
  • 23.2. North America Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mammalian Cell Culture Market

  • 24.1. USA Mammalian Cell Culture Market Overview
  • 24.2. USA Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mammalian Cell Culture Market

  • 25.1. Canada Mammalian Cell Culture Market Overview
  • 25.2. Canada Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mammalian Cell Culture Market

  • 26.1. South America Mammalian Cell Culture Market Overview
  • 26.2. South America Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mammalian Cell Culture Market

  • 27.1. Brazil Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mammalian Cell Culture Market

  • 28.1. Middle East Mammalian Cell Culture Market Overview
  • 28.2. Middle East Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mammalian Cell Culture Market

  • 29.1. Africa Mammalian Cell Culture Market Overview
  • 29.2. Africa Mammalian Cell Culture Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Mammalian Cell Culture Market, Segmentation By Cell Line, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Mammalian Cell Culture Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mammalian Cell Culture Market Competitive Landscape And Company Profiles

  • 30.1. Mammalian Cell Culture Market Competitive Landscape
  • 30.2. Mammalian Cell Culture Market Company Profiles
    • 30.2.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Mammalian Cell Culture Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company
  • 31.2. Lonza Group AG
  • 31.3. Avantor Inc.
  • 31.4. Agilent Technologies Inc.
  • 31.5. Charles river laboratories
  • 31.6. Sartorius AG
  • 31.7. Samsung biologics
  • 31.8. Wuxi biologics
  • 31.9. Bio-Techne Corporation
  • 31.10. Miltenyi Biotec
  • 31.11. STEMCELL Technologies
  • 31.12. Takara Bio Inc.
  • 31.13. Goodwin biotechnology
  • 31.14. HiMedia Laboratories Private Limited
  • 31.15. Promocell GmbH

32. Global Mammalian Cell Culture Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mammalian Cell Culture Market

34. Recent Developments In The Mammalian Cell Culture Market

35. Mammalian Cell Culture Market High Potential Countries, Segments and Strategies

  • 35.1 Mammalian Cell Culture Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Mammalian Cell Culture Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Mammalian Cell Culture Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer